0001104659-22-069760.txt : 20220609 0001104659-22-069760.hdr.sgml : 20220609 20220609180155 ACCESSION NUMBER: 0001104659-22-069760 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220609 FILED AS OF DATE: 20220609 DATE AS OF CHANGE: 20220609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KISHBAUCH MICHAEL D CENTRAL INDEX KEY: 0001076979 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 221007123 MAIL ADDRESS: STREET 1: 18 CHERRYVILLE RD CITY: FLEMINGTON STATE: NJ ZIP: 08822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Astria Therapeutics, Inc. CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: CATABASIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090127 4 1 tm2218033-7_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-06-09 0 0001454789 Astria Therapeutics, Inc. ATXS 0001076979 KISHBAUCH MICHAEL D C/O ASTRIA THERAPEUTICS, INC., 100 HIGH STREET, FLOOR 28 BOSTON MA 02110 1 0 0 0 Stock Option (right to buy) 2.99 2022-06-09 4 A 0 8333 0 A 2032-06-08 Common Stock 8333 8333 D This option was granted on June 9, 2022 and will vest in its entirety on the one-year anniversary of the grant date, subject to the director's continued service. /s/ Ben Harshbarger, as attorney-in-fact for Michael D. Kishbauch 2022-06-09